CBD is a game-changing cannabinoid found in marijuana and hemp.
Recent decades have provided us with research to show that consuming or vaping CBD does not produce a “high” associated with marijuana consumption. Yet CBD does possess myriad health benefits.
At Action Spine & Sports Medicine, our own Dr. Benjamin Cowin (DC, MS, ATC, ICSC, CAFS) is a worldwide leader in sports medicine. He is an international voice for the use of CBD in sports medicine and injury recovery.
Dr. Cowin often utilizes CBD’s evidence-based health benefits to get his patients back on the field.
Below, you’ll learn all you need to know about what CBD is, including benefits, side effects, and common questions about legal issues surrounding this potent substance.
What is CBD?
CBD is a phytocannabinoid found in the cannabis plant and accounts for 40% of the extract of cannabis. It is the second most common active ingredient in cannabis, second only to THC (tetrahydrocannabinol). CBD stands for cannabidiol.
Whereas THC is the chemical compound responsible for the psychoactive “high” often associated with marijuana, CBD is associated with many health benefits without a high.
Cannabidiol is “generally well-tolerated with a good safety profile”, according to a World Health Organization report from 2018.
What is CBD used for? CBD oil (also called hemp oil) is used for conditions including pain, anxiety, seizures and epilepsy, Parkinson’s disease, Crohn disease, acne, and blood pressure.
The endocannabinoid system is a newly understood and complex cell-signaling system that scientists didn’t identify until the 1990s. It is regulated and stimulated by phytocannabinoids like CBD and THC.
Cannabinoid receptors are located all over your body, but they’re mostly in the nervous system.
The endocannabinoid system is involved in a vast array of processes, like:
- Immune system function
- Reproductive function
- Pain sensation
- Muscle control
CBD was discovered in the 1940s. For decades, researchers believed CBD had little effect on the human body without THC. In the 1960s, breakthrough international research revealed that CBD had potential health benefits that THC, by itself, did not exhibit.
In 2015, the United States FDA (Food and Drug Administration) relaxed the regulations on researchers’ ability to source and study CBD products. This made it easier to research the health benefits of CBD.
Benefits of CBD
Medical conditions that CBD may address include:
- High blood pressure
Does CBD work? Yes, CBD works! Decades of research and mountains of evidence support CBD’s health benefits from major disease symptoms to overall well-being.
It is estimated that 50 million Americans experience chronic pain every year. A good chunk of these cases fall under chronic lower back pain, a common problem among athletes.
CBD is a known analgesic. It relieves pain when tested in human clinical trials.
Recent research supports the idea that CBD may be used to relieve chronic pain in adults.
Even skeptical researchers admit that CBD treatment for chronic pain is a reasonable treatment option for healthcare providers to consider.
CBD may relieve anxiety, a chronic mental illness affecting 40 million Americans each year. CBD may alleviate anxiety used apart from THC. In fact, THC can actually induce anxiety in some individuals, making it less than ideal to remedy this problem.
Experts estimate that up to one-third of professional athletes suffer from a mental health episode each year.
A 2015 review reveals that acute doses of CBD have the potential to treat the following anxiety-related disorders:
- Generalized anxiety disorder
- Panic disorder
- Post-traumatic stress disorder
- Obsessive-compulsive disorder
- Social anxiety disorder
Certain doses of CBD may relieve anxiety associated with public speaking. Too little or too much CBD may not help as much as that perfectly portioned dose.
Animal studies show that CBD may exhibit antidepressant effects.
High-quality CBD products seem to consistently treat depression in animal subjects. However, human clinical trials are needed to confirm whether or not this impact applies to humans.
Almost 1 in 4 households contain an individual with migraines. Migraines may occur with or without visual symptoms (called “aura”).
CBD may help relieve symptoms of migraines and other headache disorders.
According to a 2019 report, “There were significant reductions in headache and migraine ratings after cannabis use.”
Cannabinoids like CBD are promising migraine treatments due to their beneficial neurological effects and anti-inflammatory benefits.
Acne affects tens of millions of adolescents and adults in the United States alone.
Cannabinoids like CBD alleviate skin inflammation and reduce sebum production, both major causes of acne development.
These results have been produced in a lab and with animal subjects. However, these results still need to be replicated in human trials.
Alzheimer’s disease is the most common cause of dementia, which affects memory and general cognitive function. Almost 6 million Americans of all ages suffer from Alzheimer’s disease.
Early research has shown promise in relieving Alzheimer’s symptoms with CBD.
According to a 2019 review, CBD “might be useful to treat and prevent Alzheimer’s disease because CBD components suppress the main causal factors of Alzheimer’s disease.”
This same study suggests using CBD and THC together may be more effective to address Alzheimer’s.
CBD may help treat Parkinson’s disease symptoms.
Parkinson’s disease is a neurodegenerative disease most likely to affect men and individuals over the age of 50. More than 10 million people live with Parkinson’s, worldwide.
Although clinical studies are few, early clinical trials show that CBD is a promising potential treatment for movement disorders like Parkinson’s.
8. High Blood Pressure
Also called hypertension, high blood pressure is a primary or contributing cause for half a million deaths in America each year.
CBD has been shown to reduce resting blood pressure.
Studies show that CBD reduces blood pressure and heart rate in stressful conditions, but not necessarily in controlled conditions.
CBD lowered the rate of diabetes in non-obese diabetic mice in a 2005 report.
Animal studies also show that CBD may reduce diabetes-related health issues. This 2019 study shows that CBD may prevent metabolic injuries caused by diabetes in animal subjects.
So far, no high-quality research in human subjects has measured the impact on CBD on diabetes.
CBD may help addicted individuals fight substance abuse.
According to the National Survey on Drug Use and Health, 19.7 million Americans (aged 12 and up) battled with substance use in 2017.
Athletes, in particular, struggle with addiction. It’s not difficult to recall headlines about sports celebrities losing endorsement deals or even overdosing as they tried to cope with demanding expectations and being in the public eye.
CBD may be able to help curb addictions to the following substances:
- Psychostimulants (also known as “uppers”)
A 2018 study adds that CBD seems to be an effective preventative therapy for relapse.
Psychosis affects millions of people just like you. A major cause of psychosis is schizophrenia, which touches 3 million people worldwide.
By itself and in conjunction with antipsychotic medication, CBD improved psychotic symptoms “in patients with schizophrenia, with particularly promising effects in the early stages of illness.”
Certain doses of cannabinoids exhibit antitumor properties, although it seems dependent on the cancer type.
In animal studies, CBD has been shown to treat several types of cancer:
There are no high-quality studies that demonstrate whether or not CBD may work as a treatment or adjunct to cancer treatment in humans.
You should not change your cancer treatment regimen without consulting your physician.
Side Effects of CBD
The side effects of CBD are:
- Appetite changes
- Weight fluctuations
These side effects are rare, as CBD is well tolerated and safe for most individuals.
Who should NOT use CBD? If you have HIV/AIDS, tumors, or allergic lung inflammation, consult your healthcare provider before taking CBD.
As with any substance, there is a slight chance you are allergic to CBD. Usually, a CBD allergy would present as an allergic skin reaction. If you’re concerned, try a skin patch test where you apply CBD to your skin and wait a couple of days to see if any allergic symptoms arise.
CBD may negatively interact with certain medications, such as:
- Sedatives, sleep aids
- Anti-epilepsy drugs
- Blood thinners (such as Warfarin)
- Antihistamines (for example, Benadryl or Claritin)
Always consult a healthcare professional before starting a new dietary supplement, like CBD.
How to Use CBD
CBD is available in several forms:
- Edibles (such as gummies)
The first CBD medication approved by the FDA was Epidiolex, meant to treat Dravet syndrome — a complex epilepsy disorder. It hit markets in 2018.
Note: Hemp seed oil does not contain CBD.
Is CBD legal?
Pure CBD from industrial hemp is legal in all 50 states of the United States, for all ages, thanks to the 2014 and 2018 Farm Bill. Bipartisan support in the US legislature is determined to make hemp and CBD more accessible, not less.
Is CBD a drug? According to the US government, CBD is an illegal Schedule I drug if it was extracted from marijuana. CBD is legal if extracted from the hemp plant. The levels of THC present in the original plant and the final product determines if CBD is an illegal drug or not.
Unfortunately, the federal government is in a slow transition phase of approving CBD as a legal and accessible Schedule V drug that possesses evidence-based health benefits.
Concerted legislative efforts need to be made to distinguish medical marijuana (medical cannabis) and hemp products.
Does CBD show up on a drug test? CBD by itself will not show up on a drug test. However, THC will show up on a drug test. CBD often contains trace amounts of THC. This means that using CBD may occasionally show up on a drug test as THC.
If you are going to be taking a drug test, avoid full-spectrum CBD. Instead, look for broad-spectrum CBD without THC.
CBD vs. THC
CBD (cannabidiol) is the non-intoxicating compound found in cannabis. THC (tetrahydrocannabinol) is the psychoactive compound in cannabis, which can get you high.
CBD may result in health benefits such as the reduction of anxiety and depression symptoms and pain relief.
While CBD oil extract from hemp is legal all across America, THC and marijuana are still considered fully illegal in 8 states.
Another 10 states only allow medicinal use of marijuana and THC. In Colorado, marijuana, THC, and CBD are all completely legal.
Some experts advocate for using CBD and THC together, citing the “entourage effect”. Effectively, this means that they are greater than the sum of their parts when consumed in tandem.
Here at Action Spine & Sports Medicine, Dr. Benjamin Cowin and his team utilize evidence-based treatment plans to get you back on your feet as quickly and safely as possible. Dr. Cowin is an international leader of CBD in sports medicine.
Click here or call us today at (720) 541-7098, and set up your appointment with Action Spine & Sports Medicine in Denver, CO.
- Russo, E. B. (2008). Cannabinoids in the management of difficult to treat pain. Therapeutics and clinical risk management, 4(1), 245. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
- Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018). Cannabinoids and pain: new insights from old molecules. Frontiers in pharmacology, 9, 1259. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/
- Hill, K. P., Palastro, M. D., Johnson, B., & Ditre, J. W. (2017). Cannabis and pain: a clinical review. Cannabis and cannabinoid research, 2(1), 96-104. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549367/
- Shannon, S., & Opila-Lehman, J. (2016). Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report. The Permanente Journal, 20(4). Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101100/
- Reardon, C. L., Hainline, B., Aron, C. M., Baron, D., Baum, A. L., Bindra, A., … & Derevensky, J. L. (2019). Mental health in elite athletes: International Olympic Committee consensus statement (2019). British Journal of Sports Medicine, 53(11), 667-699. Abstract: https://pubmed.ncbi.nlm.nih.gov/31097450/
- Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825-836. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/
- Linares, I. M., Zuardi, A. W., Pereira, L. C., Queiroz, R. H., Mechoulam, R., Guimaraes, F. S., & Crippa, J. A. (2019). Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Brazilian Journal of Psychiatry, 41(1), 9-14. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781714/
- Zanelati, T. V., Biojone, C., Moreira, F. A., Guimaraes, F. S., & Joca, S. R. (2010). Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1A receptors. British journal of pharmacology, 159(1), 122-128. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823358/
- El-Alfy, A. T., Ivey, K., Robinson, K., Ahmed, S., Radwan, M., Slade, D., … & Ross, S. (2010). Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacology Biochemistry and Behavior, 95(4), 434-442. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866040/
- Cuttler, C., Spradlin, A., Cleveland, M. J., & Craft, R. M. (2019). Short-and long-term effects of cannabis on headache and migraine. The Journal of Pain. Full text: https://www.sciencedirect.com/science/article/pii/S152659001930848X
- Leimuranta, P., Khiroug, L., & Giniatullin, R. (2018). Emerging role of (endo) cannabinoids in migraine. Frontiers in pharmacology, 9, 420. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928495/
- Oláh, A., Tóth, B. I., Borbíró, I., Sugawara, K., Szöllõsi, A. G., Czifra, G., … & Ludovici, M. (2014). Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes. The Journal of clinical investigation, 124(9), 3713-3724. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/
- Scheau, C., Badarau, I. A., Mihai, L. G., Scheau, A. E., Costache, D. O., Constantin, C., … & Caruntu, A. (2020). Cannabinoids in the Pathophysiology of Skin Inflammation. Molecules, 25(3), 652. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037408/
- Watt, G., & Karl, T. (2017). In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer’s disease. Frontiers in pharmacology, 8, 20. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289988/
- Kim, S. H., Yang, J. W., Kim, K. H., Kim, J. U., & Yook, T. H. (2019). A Review on Studies of Marijuana for Alzheimer’s Disease–Focusing on CBD, THC. Journal of Pharmacopuncture, 22(4), 225. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970569/
- Rieder, C. R. (2020). Cannabidiol in Parkinson’s disease. Brazilian Journal of Psychiatry, 42(2), 126-127. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115444/
- Peres, F. F., Lima, A. C., Hallak, J. E., Crippa, J. A., Silva, R. H., & Abílio, V. C. (2018). Cannabidiol as a promising strategy to treat and prevent movement disorders?. Frontiers in pharmacology, 9, 482. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958190/
- Jadoon, K. A., Tan, G. D., & O’Sullivan, S. E. (2017). A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study. JCI insight, 2(12). Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470879/
- Sultan, S. R., Millar, S. A., England, T. J., & O’Sullivan, S. E. (2017). A systematic review and meta-analysis of the haemodynamic effects of cannabidiol. Frontiers in pharmacology, 8, 81. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323388/
- Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2006). Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity, 39(2), 143-151. Full text: https://www.researchgate.net/profile/Ruth_Gallily/publication/7082152_Cannabidiol_lowers_incidence_of_diabetes_in_non-obese_diabetic_mice/links/09e4150f68407782fd000000.pdf
- Zorzenon, M. R. T., Santiago, A. N., Mori, M. A., Piovan, S., Jansen, C. A., Padilha, M. E. P., … & Milani, P. G. (2019). Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion. Chemico-biological interactions, 312, 108819. Abstract: https://pubmed.ncbi.nlm.nih.gov/31499052/
- Calpe-López, C., García-Pardo, M. P., & Aguilar, M. A. (2019). Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms. Molecules, 24(14), 2583. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680550/
- Prud’homme, M., Cata, R., & Jutras-Aswad, D. (2015). Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence. Substance abuse: research and treatment, 9, SART-S25081. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
- Gonzalez-Cuevas, G., Martin-Fardon, R., Kerr, T. M., Stouffer, D. G., Parsons, L. H., Hammell, D. C., … & Weiss, F. (2018). Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle. Neuropsychopharmacology, 43(10), 2036-2045. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098033/
- Davies, C., & Bhattacharyya, S. (2019). Cannabidiol as a potential treatment for psychosis. Therapeutic advances in psychopharmacology, 9, 2045125319881916. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/
- Iseger, T. A., & Bossong, M. G. (2015). A systematic review of the antipsychotic properties of cannabidiol in humans. Schizophrenia research, 162(1-3), 153-161. Abstract: https://pubmed.ncbi.nlm.nih.gov/25667194/
- Dariš, B., Verboten, M. T., Knez, Ž., & Ferk, P. (2019). Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosnian journal of basic medical sciences, 19(1), 14. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387667/
- Batalla, A., Janssen, H., Gangadin, S. S., & Bossong, M. G. (2019). The potential of cannabidiol as a treatment for psychosis and addiction: who benefits most? A systematic review. Journal of clinical medicine, 8(7), 1058. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678854/
- Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010). Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. Journal of pain and symptom management, 39(2), 167-179. Full text: https://www.sciencedirect.com/science/article/pii/S0885392409007878
- Bloechl-Daum, B., Deuson, R. R., Mavros, P., Hansen, M., & Herrstedt, J. (2006). Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. Journal of clinical oncology, 24(27), 4472-4478. Abstract: https://pubmed.ncbi.nlm.nih.gov/16983116/
- McAllister, S. D., Soroceanu, L., & Desprez, P. Y. (2015). The antitumor activity of plant-derived non-psychoactive cannabinoids. Journal of neuroimmune pharmacology, 10(2), 255-267. Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470774/
- Srivastava, M. D., Srivastava, B. I. S., & Brouhard, B. (1998). Δ9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology, 40(3), 179-185. Full text: https://www.druglibrary.net/crl/immune/Srivastava_et.al_98_Cytokine_Production_Immunopharmacol.pdf
- Gaston, T. E., Bebin, E. M., Cutter, G. R., Liu, Y., Szaflarski, J. P., & UAB CBD Program. (2017). Interactions between cannabidiol and commonly used antiepileptic drugs. Epilepsia, 58(9), 1586-1592. Full text: https://onlinelibrary.wiley.com/doi/full/10.1111/epi.13852